Milestone Pharmaceuticals Inc. (MIST) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Milestone Pharmaceuticals Inc. (MIST).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $1.54

Daily Change: $0.00 / 0.00%

Daily Range: $1.50 - $1.56

Market Cap: $129,995,384

Daily Volume: 590,077

Performance Metrics

1 Week: 5.52%

1 Month: -32.00%

3 Months: 19.53%

6 Months: -23.12%

1 Year: 14.18%

YTD: -35.17%

Company Details

Employees: 33

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Selected stocks

Huntington Bancshares Incorporated (HBAN)

HSBC Holdings, plc. (HSBC)

Fulton Financial Corporation - Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A (FULTP)